Sherry A Pierce Selected Research

Sherry A Pierce Research Topics

14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 06/2002
6	Neoplasms (Cancer) 11/2023 - 03/2004
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 06/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2016
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2006 - 01/2002
2	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 07/2019
2	Anemia 04/2024 - 06/2002
2	Disease Progression 01/2019 - 10/2013
2	Infections 03/2004 - 01/2002
2	Acute Promyelocytic Leukemia 03/2004 - 06/2002
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023
1	Leukemia 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 05/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2018
1	Thrombocytopenia (Thrombopenia) 05/2017
1	Philadelphia Chromosome 08/2015
1	Atrial Fibrillation 10/2013
1	Death (Near-Death Experience) 10/2013
1	Respiratory Insufficiency (Respiratory Failure) 10/2013
1	Renal Insufficiency (Renal Failure) 10/2013
1	Lymphoma (Lymphomas) 04/2006
1	Hyperglycemia 03/2004
1	Pathologic Complete Response 06/2002
1	Hematologic Neoplasms (Hematological Malignancy) 01/2002
1	Mucositis 01/2002

4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 06/2002
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2016
3	Azacitidine (5 Azacytidine)FDA Link 11/2021 - 01/2019
3	venetoclaxIBA 01/2021 - 01/2021
2	Decitabine FDA Link 01/2021 - 01/2020
2	ruxolitinibIBA 01/2020 - 07/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2004 - 01/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2004 - 01/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2004 - 01/2002
2	Vincristine (Oncovin)FDA LinkGeneric 03/2004 - 01/2002
2	Gemtuzumab (Mylotarg)FDA Link 06/2002 - 06/2002
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2002 - 06/2002
1	ACE-011IBA 04/2024
1	Cladribine FDA LinkGeneric 01/2023
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2023
1	Programmed Cell Death 1 ReceptorIBA 11/2021
1	pembrolizumabIBA 11/2021
1	LigandsIBA 11/2021
1	avelumabIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	isavuconazoleIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	NivolumabIBA 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 04/2006
1	Methylprednisolone FDA LinkGeneric 03/2004
1	Methotrexate (Mexate)FDA LinkGeneric 03/2004
1	Glucose (Dextrose)FDA LinkGeneric 03/2004
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 03/2004
1	HLA-DR Antigens (HLA-DR)IBA 03/2004
1	Interleukin-11 (Interleukin 11)IBA 06/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2002
1	Filgrastim (Neupogen)FDA Link 01/2002

10	Therapeutics 11/2023 - 11/2011
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
2	Remission Induction 01/2021 - 01/2002
2	Salvage Therapy 01/2018 - 10/2013
2	Induction Chemotherapy 03/2004 - 01/2002
1	Stem Cell Transplantation 01/2023
1	Artificial Respiration (Mechanical Ventilation) 10/2013
1	Consolidation Chemotherapy 01/2002